• Investors
  • News
  • Contact
Iconovo
  • About us
    • Board of Directors
    • Management
    • Our Team
    • Sustainability
    • Career
    • Investors
  • Inhalers
    • Inhalers
    • ICOres
    • ICOcap
    • ICOpre
    • ICOone
    • ICOone Nasal
    • Patents
  • Development services
    • Development services
    • Inhalers
    • Formulation
    • Pharmaceutical Analysis
    • Advisory services
  • Partner with us
    • Partner with us
    • Iconovo Accelerator Program
  • Insights
    • Replacing injections with inhalation
    • Boost your business with an innovative inhaler partner
  • Investors
  • Search
  • Menu Menu
  • LinkedIn

Meet us at RDD

We enable effective inhalation

Respiratory Drug Delivery  is the biggest international event in inhaled medicine this year, taking place in Antibes, May 2-5. RDD is a premier, international conference series providing comprehensive coverage of all aspects of drug delivery to the lungs and nose. RDD has a 35-year track record of inviting key opinion leaders to present scientific, clinical, technological, and regulatory insights of immediate and lasting value to individuals and organizations, in an environment that stimulates introductions, networking and collaboration.

Iconovo will participate at RDD, demonstrating how we can enable effective inhalation. You are most welcome to meet us there, to learn more about how you can boost your business with our innovative inhalation platforms.

To book a personal meeting with us at RDD, please send us an e-mail.

OUR VISION

We radically transform inhaled drug therapy by providing unique devices with tailored dry powder formulations

See our products

Orest Lastow

CTO and Founder

Roger Lassing 

VP Business Development

Contact me

Catharina Ahlenius 

Project Manager

Måns Österberg

Director Alliance Management

Contact me

Want to be up to date with with our platforms and news in inhalation?

Sign up for our newsletters now!

You can trust us with your email-address. We will send you four newsletters per year with news on our platforms. No more, no less.

Possessing a unique combination

of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

ICONOVO AB

VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B

POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden

CONTACT

Phone: +46 46 275 67 77

VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se

CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se

SITEMAP

  • Home
  • Development services
  • Investors

Press releases

Subscribe

Follow us on Linkedin

Scroll to top